Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy
Academic Article
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- January 1992
has subject area
- 11 Medical and Health Sciences (FoR)
- Age Factors (MeSH)
- Aged (MeSH)
- Antineoplastic Combined Chemotherapy Protocols (MeSH)
- Breast Neoplasms (MeSH)
- Chemotherapy, Adjuvant (MeSH)
- Cisplatin (MeSH)
- Female (MeSH)
- Fluorouracil (MeSH)
- General & Internal Medicine (Science Metrix)
- Global Health (MeSH)
- Humans (MeSH)
- Immunotherapy (MeSH)
- Methotrexate (MeSH)
- Middle Aged (MeSH)
- Multicenter Studies as Topic (MeSH)
- Neoplasm Recurrence, Local (MeSH)
- Ovariectomy (MeSH)
- Randomized Controlled Trials as Topic (MeSH)
- Survival Analysis (MeSH)
- Tamoxifen (MeSH)
- Time Factors (MeSH)
- Treatment Outcome (MeSH)
published in
- The Lancet Journal